Novo Nordisk A/S ADR buy Cantor Fitzgerald
Start price
01.04.24
/
50%
€120.00
Target price
01.04.25
€148.38
Performance (%)
-2.50%
Price
26.07.24
€117.00
Summary
This prediction is currently active. With a performance of -2.50%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 01.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | -3.306% | -3.306% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $160.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€136.00
01.07.24
01.07.24
€149.06
01.07.25
01.07.25
-13.97%
26.07.24
26.07.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€131.50
17.06.24
17.06.24
€149.06
17.06.25
17.06.25
-11.03%
26.07.24
26.07.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€121.00
20.03.24
20.03.24
€147.49
20.03.25
20.03.25
-2.80%
26.07.24
26.07.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€112.50
20.02.24
20.02.24
€129.46
20.02.25
20.02.25
4.55%
26.07.24
26.07.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€114.00
14.02.24
14.02.24
€130.44
14.02.25
14.02.25
3.17%
26.07.24
26.07.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€106.50
01.02.24
01.02.24
€128.80
01.02.25
01.02.25
10.44%
26.07.24
26.07.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.20
01.12.23
01.12.23
€110.39
01.12.24
01.12.24
26.20%
26.07.24
26.07.24